289 related articles for article (PubMed ID: 14533846)
1. Decreased activity of cathepsins L + B and decreased invasive ability of PC3 prostate cancer cells.
Colella R; Casey SF
Biotech Histochem; 2003 Apr; 78(2):101-8. PubMed ID: 14533846
[TBL] [Abstract][Full Text] [Related]
2. Increased cell density decreases cysteine proteinase inhibitor activity and increases invasive ability of two prostate tumor cell lines.
Colella R; Goodwyn E; Gopal P
Cancer Lett; 2002 Nov; 185(2):163-72. PubMed ID: 12169390
[TBL] [Abstract][Full Text] [Related]
3. Matrigel invasion by the prostate cancer cell lines, PC3 and DU145, and cathepsin L+B activity.
Colella R; Jackson T; Goodwyn E
Biotech Histochem; 2004; 79(3-4):121-7. PubMed ID: 15621884
[TBL] [Abstract][Full Text] [Related]
4. Matrigel influences morphology and cathepsin B distribution of prostate cancer PC3 cells.
Gopal P; Rehman RU; Chadha KS; Qiu M; Colella R
Oncol Rep; 2006 Aug; 16(2):313-20. PubMed ID: 16820909
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of the sugarcane cystatin CaneCPI-4 on cathepsins B and L and human breast cancer cell invasion.
Gianotti A; Sommer CA; Carmona AK; Henrique-Silva F
Biol Chem; 2008 Apr; 389(4):447-53. PubMed ID: 18208350
[TBL] [Abstract][Full Text] [Related]
6. Modulation of invasive properties of murine squamous carcinoma cells by heterologous expression of cathepsin B and cystatin C.
Coulibaly S; Schwihla H; Abrahamson M; Albini A; Cerni C; Clark JL; Ng KM; Katunuma N; Schlappack O; Glössl J; Mach L
Int J Cancer; 1999 Nov; 83(4):526-31. PubMed ID: 10508490
[TBL] [Abstract][Full Text] [Related]
7. Invasion of ras-transformed breast epithelial cells depends on the proteolytic activity of cysteine and aspartic proteinases.
Premzl A; Puizdar V; Zavasnik-Bergant V; Kopitar-Jerala N; Lah TT; Katunuma N; Sloane BF; Turk V; Kos J
Biol Chem; 2001 May; 382(5):853-7. PubMed ID: 11517941
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of cathepsins L and B and decreased activity of their inhibitors in metastatic, ras-transformed NIH 3T3 cells.
Chambers AF; Colella R; Denhardt DT; Wilson SM
Mol Carcinog; 1992; 5(3):238-45. PubMed ID: 1586450
[TBL] [Abstract][Full Text] [Related]
9. Expression of cysteine peptidase cathepsin L and its inhibitors stefins A and B in relation to tumorigenicity of breast cancer cell lines.
Zajc I; Sever N; Bervar A; Lah TT
Cancer Lett; 2002 Dec; 187(1-2):185-90. PubMed ID: 12359367
[TBL] [Abstract][Full Text] [Related]
10. Cathepsins B and L and their inhibitors stefin B and cystatin C as markers for malignant progression of benign meningiomas.
Trinkaus M; Vranic A; Dolenc VV; Lah TT
Int J Biol Markers; 2005; 20(1):50-9. PubMed ID: 15832773
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of carcinoma cell invasion and liver metastases formation by the cysteine proteinase inhibitor E-64.
Navab R; Mort JS; Brodt P
Clin Exp Metastasis; 1997 Mar; 15(2):121-9. PubMed ID: 9062388
[TBL] [Abstract][Full Text] [Related]
12. Post-translational regulation of cathepsin B, but not of other cysteine cathepsins, contributes to increased glioblastoma cell invasiveness in vitro.
Gole B; Durán Alonso MB; Dolenc V; Lah T
Pathol Oncol Res; 2009 Dec; 15(4):711-23. PubMed ID: 19434518
[TBL] [Abstract][Full Text] [Related]
13. The expression and function of cystatin C and cathepsin B and cathepsin L during mouse embryo implantation and placentation.
Afonso S; Romagnano L; Babiarz B
Development; 1997 Sep; 124(17):3415-25. PubMed ID: 9310336
[TBL] [Abstract][Full Text] [Related]
14. Collagenolytic cathepsins of rabbit spleen: a kinetic analysis of collagen degradation and inhibition by chicken cystatin.
Maciewicz RA; Etherington DJ; Kos J; Turk V
Coll Relat Res; 1987 Sep; 7(4):295-304. PubMed ID: 3665403
[TBL] [Abstract][Full Text] [Related]
15. Regulation of cathepsin B and L expression in vitro in gastric cancer tissues by egg cystatin.
Saleh Y; Siewiński M; Kielan W; Ziółkowski P; Gryboś M; Rybka J
J Exp Ther Oncol; 2003; 3(6):319-24. PubMed ID: 14678520
[TBL] [Abstract][Full Text] [Related]
16. Cysteine proteases and cysteine protease inhibitors in non-small cell lung cancer.
Krepela E; Procházka J; Kárová B; Cermák J; Roubková H
Neoplasma; 1998; 45(5):318-31. PubMed ID: 9921922
[TBL] [Abstract][Full Text] [Related]
17. Expression of cysteine proteinases cathepsins B and K and of cysteine proteinase inhibitor cystatin C in giant cell tumor of tendon sheath.
Hansen T; Petrow PK; Gaumann A; Keyszer GM; Otto M; Kirkpatrick CJ; Kriegsmann J
Mod Pathol; 2001 Apr; 14(4):318-24. PubMed ID: 11301348
[TBL] [Abstract][Full Text] [Related]
18. Cathepsins B, H, L and cysteine protease inhibitors in malignant prostate cell lines, primary cultured prostatic cells and prostatic tissue.
Friedrich B; Jung K; Lein M; Türk I; Rudolph B; Hampel G; Schnorr D; Loening SA
Eur J Cancer; 1999 Jan; 35(1):138-44. PubMed ID: 10211102
[TBL] [Abstract][Full Text] [Related]
19. The contribution of N-terminal region residues of cystatin A (stefin A) to the affinity and kinetics of inhibition of papain, cathepsin B, and cathepsin L.
Estrada S; Pavlova A; Björk I
Biochemistry; 1999 Jun; 38(22):7339-45. PubMed ID: 10353845
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of cathepsins B and L compared with matrix metalloproteinases and their respective inhibitors in rheumatoid arthritis and osteoarthritis: a parallel investigation by semiquantitative reverse transcriptase-polymerase chain reaction and immunohistochemistry.
Keyszer G; Redlich A; Häupl T; Zacher J; Sparmann M; Engethüm U; Gay S; Burmester GR
Arthritis Rheum; 1998 Aug; 41(8):1378-87. PubMed ID: 9704635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
